| scholarly article | Q13442814 |
| P2093 | author name string | Yunfang Li | |
| David L Hermanson | |||
| Chengguo Xing | |||
| Ameeta Kelekar | |||
| Nicholas Bleeker | |||
| Sonia G Das | |||
| Xazmin Lowman | |||
| P2860 | cites work | Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function | Q24293924 |
| Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins | Q24302494 | ||
| Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes | Q24317668 | ||
| Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis | Q27693212 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| Mitochondria and apoptosis | Q29547905 | ||
| The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
| BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis | Q29620466 | ||
| Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics | Q29620467 | ||
| P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients | Q33472987 | ||
| Apoptotic pathways: the roads to ruin | Q34753431 | ||
| Calcium and apoptosis: facts and hypotheses | Q35591703 | ||
| Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis | Q36088654 | ||
| Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. | Q36322335 | ||
| Microdomains of intracellular Ca2+: molecular determinants and functional consequences. | Q36350079 | ||
| Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes | Q36747950 | ||
| Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes | Q36799170 | ||
| Is resistance useless? Multidrug resistance and collateral sensitivity | Q37414081 | ||
| Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues | Q39502559 | ||
| Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues | Q39801240 | ||
| Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria. | Q39832035 | ||
| The antiproliferative effect of EPA in HL60 cells is mediated by alterations in calcium homeostasis | Q39914245 | ||
| Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma | Q40124624 | ||
| sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell | Q40150613 | ||
| Clinical relevance of P-glycoprotein expression in haematological malignancies | Q40622503 | ||
| Modulation of endoplasmic reticulum calcium pump by Bcl-2. | Q41000205 | ||
| Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma. | Q41047474 | ||
| Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). | Q42808518 | ||
| Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression. | Q42815155 | ||
| Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells. | Q43257172 | ||
| Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines | Q43864431 | ||
| Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy | Q44325712 | ||
| Bcl-2 suppresses Ca2+ release through inositol 1,4,5-trisphosphate receptors and inhibits Ca2+ uptake by mitochondria without affecting ER calcium store content | Q44570171 | ||
| A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. | Q46183389 | ||
| Bcl-2 family proteins | Q46508339 | ||
| New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents | Q46817128 | ||
| Displacement of SERCA from SR lipid caveolae-related domains by Bcl-2: a possible mechanism for SERCA inactivation | Q46875789 | ||
| High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia. | Q52530287 | ||
| The hedgehog pathway inhibitor GDC-0449 alters intracellular Ca2+ homeostasis and inhibits cell growth in cisplatin-resistant lung cancer cells. | Q53194732 | ||
| Apoptosis. Death deceiver. | Q53427719 | ||
| Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia. | Q53608454 | ||
| Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis. | Q54340874 | ||
| Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA) | Q57219095 | ||
| Subcellular localization of bcl-2 protein | Q67997984 | ||
| Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK) | Q73807506 | ||
| MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients | Q74710902 | ||
| [The relationship between abnormal MDR gene expression and chemotherapy response in lymphoid malignancies] | Q79255214 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 327-335 | |
| P577 | publication date | 2012-11-05 | |
| P1433 | published in | ACS Chemical Biology | Q165583 |
| P1476 | title | Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017): a novel scaffold that resensitizes multidrug resistant leukemia cells to chemotherapy | |
| P478 | volume | 8 |
| Q38909364 | 4H-Chromene-based anticancer agents towards multi-drug resistant HL60/MX2 human leukemia: SAR at the 4th and 6th positions |
| Q58200581 | A Facile and Convenient Synthesis of Chromenes using Reusable Sulfonic Acid Functionalized Imidazolium Salt |
| Q39089915 | A novel SERCA inhibitor demonstrates synergy with classic SERCA inhibitors and targets multidrug-resistant AML. |
| Q90494509 | An Indole-Chalcone Inhibits Multidrug-Resistant Cancer Cell Growth by Targeting Microtubules |
| Q57170103 | Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells |
| Q58200651 | Indium triflate catalyzed microwave-assisted alkenylation of methoxyphenols: synthesis of indenes and chromenes |
| Q38388828 | Mechanisms and therapeutic potential of inhibiting drug efflux transporters |
| Q37027063 | Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia |
| Q33763765 | Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance |
Search more.